Back
BioInvent International AB Vs. Hansa Biopharma AB Industry Stock Comparison
Buy
61
BOVNF
BioInvent International AB
Last Price:
4.70
Seasonality Move:
-13.26%
Sell
39
HNSBF
Hansa Biopharma AB
Last Price:
2.83
Seasonality Move:
-0.32%
Buy
61
BioInvent International AB (BOVNF)
is a Buy
Is BioInvent International AB a Buy, Sell or Hold?
- The current BioInvent International AB [BOVNF] share price is $4.70. The Score for BOVNF is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- BOVNF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Hansa Biopharma AB (HNSBF)
is a Sell
Is Hansa Biopharma AB a Buy, Sell or Hold?
- The current Hansa Biopharma AB [HNSBF] share price is $2.83. The Score for HNSBF is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- HNSBF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BOVNF Stock Price Chart
What is BioInvent International AB's stock price today?
-
The BioInvent International AB share price today is $4.70
The current trend is relatively stagnant and BOVNF is experiencing slight buying pressure.
HNSBF Stock Price Chart
What is Hansa Biopharma AB's stock price today?
-
The Hansa Biopharma AB share price today is $2.83
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HNSBF is experiencing slight buying pressure.
BOVNF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0 | Buy |
Relative Strength Index (14 RSI): | 0 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.7 - 4.7) | Sell |
Bollinger Bands (100): | (4.7 - 4.7) | Sell |
HNSBF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.16 | Sell |
Relative Strength Index (14 RSI): | 8.68 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.16 - 3.82) | Sell |
Bollinger Bands (100): | (2.81 - 3.47) | Sell |
BOVNF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.7 | Sell |
20-day SMA: | 4.7 | Sell |
50-day SMA: | 4.7 | Sell |
200-day SMA: | 4.7 | Sell |
8-day EMA: | 4.7 | Sell |
20-day EMA: | 4.7 | Buy |
50-day EMA: | 4.7 | Buy |
200-day EMA: | 5.34 | Sell |
HNSBF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.14 | Sell |
20-day SMA: | 3.45 | Sell |
50-day SMA: | 3.35 | Sell |
200-day SMA: | 3.06 | Sell |
8-day EMA: | 3.06 | Sell |
20-day EMA: | 3.31 | Sell |
50-day EMA: | 3.33 | Sell |
200-day EMA: | 3.66 | Sell |
BioInvent International AB Earnings Growth & BOVNF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Hansa Biopharma AB Earnings Growth & HNSBF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
BioInvent International AB Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Hansa Biopharma AB Technical Analysis
Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | Dec | |||||||||
26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |